| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0001 | 1 |